Structure

InChI Key SEBFKMXJBCUCAI-DBMPWETRSA-N
Smiles COc1cc(C2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3OC2CO)ccc1O
InChI
InChI=1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20?,23-,24?,25+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C25H22O10
Molecular Weight 482.44
AlogP 2.36
Hydrogen Bond Acceptor 10.0
Hydrogen Bond Donor 5.0
Number of Rotational Bond 4.0
Polar Surface Area 155.14
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 35.0
Assay Description Organism Bioactivity Reference
Inhibitory activity derived from Anastatica hierochuntica on D-Gal-induced cytotoxicity in primary cultured mouse hepatocytes at a concentration of 0 uM Mus musculus 0.0 %
Inhibitory activity derived from Anastatica hierochuntica on D-Gal-induced cytotoxicity in primary cultured mouse hepatocytes at a concentration of 10 uM Mus musculus 7.7 %
Inhibitory activity derived from Anastatica hierochuntica on D-Gal-induced cytotoxicity in primary cultured mouse hepatocytes at a concentration of 3 uM Mus musculus 4.8 %
Inhibitory activity derived from Anastatica hierochuntica on D-Gal-induced cytotoxicity in primary cultured mouse hepatocytes at a concentration of 30 uM Mus musculus 45.2 %
Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes at 100 uM treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay relative to control Mus musculus 129.0 %
Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes at 50 uM treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay relative to control Mus musculus 68.2 %
Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes at 25 uM treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay relative to control Mus musculus 44.9 %
Hepatoprotective activity in mouse hepatocytes assessed inhibition of D-galactosamine/TNFalpha-induced cell death at 12.5 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs Mus musculus 43.4 %
Hepatoprotective activity in mouse hepatocytes assessed inhibition of D-galactosamine/TNFalpha-induced cell death at 25 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs Mus musculus 99.7 %
Hepatoprotective activity in mouse hepatocytes assessed inhibition of D-galactosamine/TNFalpha-induced cell death at 50 uM administered before 30 mins of TNFalpha challenge measured after 18 hrs Mus musculus 149.7 %
Hepatoprotective activity against mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cell death at 25 uM after 18 hrs by MTT assay Mus musculus 38.1 %
Hepatoprotective activity against mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cell death at 50 uM after 18 hrs by MTT assay Mus musculus 61.2 %
Hepatoprotective activity against mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cell death at 100 uM after 18 hrs by MTT assay Mus musculus 96.5 %
Hepatoprotective activity against mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cell death at 200 uM after 18 hrs by MTT assay Mus musculus 70.8 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 3 uM after 44 hrs by MTT assay relative to control Mus musculus 4.8 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 10 uM after 44 hrs by MTT assay relative to control Mus musculus 7.7 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 30 uM after 44 hrs by MTT assay relative to control Mus musculus 45.2 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 100 uM after 44 hrs by MTT assay relative to control Mus musculus 77.0 %
Inhibition of bovine xanthine oxidase assessed as reduction in xanthine turnover at 10 uM Bos taurus 50.0 %
Inhibition of bovine xanthine oxidase assessed as reduction in xanthine turnover at 25 uM Bos taurus 50.0 %
Inhibition of bovine xanthine oxidase assessed as reduction in xanthine turnover at 50 uM Bos taurus 50.0 %
Inhibition of bovine xanthine oxidase assessed as decrease in production of superoxide at 50 uM relative to control Bos taurus 20.0 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 3 uM after 44 hrs by MTT assay relative to untreated control Mus musculus 5.0 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 10 uM after 44 hrs by MTT assay relative to untreated control Mus musculus 8.0 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 30 uM after 44 hrs by MTT assay relative to untreated control Mus musculus 45.0 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 100 uM after 44 hrs by MTT assay relative to untreated control Mus musculus 77.0 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity at 1 uM after 20 hrs by MTT assay relative to untreated control Mus musculus 11.0 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity at 3 uM after 20 hrs by MTT assay relative to untreated control Mus musculus 19.0 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity at 10 uM after 20 hrs by MTT assay relative to untreated control Mus musculus 37.0 %
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity at 30 uM after 20 hrs by MTT assay relative to untreated control Mus musculus 93.0 %
Hepatoprotective activity in ddY mouse primary cultured hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 3 ug/mL after 44 hrs by MTT assay Mus musculus 4.8 %
Hepatoprotective activity in ddY mouse primary cultured hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 10 ug/mL after 44 hrs by MTT assay Mus musculus 7.7 %
Hepatoprotective activity in ddY mouse primary cultured hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 30 ug/mL after 44 hrs by MTT assay Mus musculus 45.2 %
Hepatoprotective activity in ddY mouse primary cultured hepatocytes assessed as inhibition of D-galactosamine-induced cytotoxicity at 100 ug/mL after 44 hrs by MTT assay Mus musculus 77.0 %
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity at 3 ug/mL after 44 hrs by MTT assay Mus musculus 5.3 %
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity at 10 ug/mL after 44 hrs by MTT assay Mus musculus 22.0 %
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity at 30 ug/mL after 44 hrs by MTT assay Mus musculus 48.0 %
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity at 100 ug/mL after 44 hrs by MTT assay Mus musculus 50.8 %
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity after 44 hrs by MTT assay Mus musculus 60.4 ug.mL-1
Cytoprotective activity in human embryo L02 cells assessed as inhibition of D-galactosamine-induced cytotoxicity at 6.25 ug/ml treated for 1 hr prior to D-galactosamine challenge measured after 48 hrs by MTT assay relative to control Homo sapiens 28.2 %
Cytoprotective activity in human embryo L02 cells assessed as inhibition of D-galactosamine-induced cytotoxicity at 3.13 ug/ml treated for 1 hr prior to D-galactosamine challenge measured after 48 hrs by MTT assay relative to control Homo sapiens 33.4 %
Cytoprotective activity in human embryo L02 cells assessed as inhibition of D-galactosamine-induced cytotoxicity at 1.56 ug/ml treated for 1 hr prior to D-galactosamine challenge measured after 48 hrs by MTT assay relative to control Homo sapiens 10.1 %
Inhibition of electric eel AChE at 2 mg/ml by Ellman's method Electrophorus electricus 7.08 %
Inhibition of horse BChE at 2 mg/ml by Ellman's method Equus caballus -7.94 %
Inhibition of electric eel AChE at 100 uM by colorimetric Ellman assay Electrophorus electricus 5.5 %
Inhibition of horse AChE at 100 uM by colorimetric Ellman assay Equus caballus 3.1 %
Inhibition of human thrombin assessed as decrease in platelet aggregation at 1000 uM preincubated for 10 mins measured for 10 mins by dual channel chrono-log aggregometric analysis relative to control Homo sapiens 43.0 %
Inhibition of Wnt/beta-catenin signaling pathway in human HEK293 cells at 20 uM after 24 hrs by dual luciferase reporter gene assay relative to vehicle-treated control Homo sapiens 8.3 %
Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 54.77 %
Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 46.89 %
Inhibition of biofilm formation in Staphylococcus aureus 8325-4 after 24 hrs by microtiter plate assay Staphylococcus aureus 64.0 ug.mL-1
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production at 1 uM after 24 hrs by ELISA relative to control Mus musculus 10.3 %
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production at 10 uM after 24 hrs by ELISA relative to control Mus musculus 27.0 %
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production at 50 uM after 24 hrs by ELISA relative to control Mus musculus 47.0 %
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production at 100 uM after 24 hrs by ELISA relative to control Mus musculus 53.8 %
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 10 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 1%) Homo sapiens 4.8 %
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation at 100 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0 +/- 4.4%) Homo sapiens 16.0 %
Inhibition of tau (unknown origin) aggregation expressed in Escherichia coli (DE3) at 10 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0.0 +/- 1.4%) Homo sapiens 2.0 %
Inhibition of tau (unknown origin) aggregation expressed in Escherichia coli (DE3) at 100 uM incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer (Rvb = 0.0 +/- 2.4%) Homo sapiens 10.1 %
Mixed type inhibition of monophenolase activity of mushroom tyrosinase assessed as reduction in dopachrome formation using L-Tyrosine substrate by UV-Vis spectrophotometry based Dixon plot analysis Agaricus bisporus 700.0 nM
Inhibition of monophenolase activity of mushroom tyrosinase assessed as inhibition constant for free enzyme-inhibitor complex by measuring reduction in dopachrome formation using L-Tyrosine substrate by UV-Vis spectrophotometry Agaricus bisporus 700.0 nM
Inhibition of F1F0-ATP synthase in Escherichia coli after 60 mins relative to control Escherichia coli 100.0 %

Related Entries

Cross References

Resources Reference
ChEMBL CHEMBL9509
FDA SRS 4RKY41TBTF
SureChEMBL SCHEMBL22398934